Hepatocellular carcinoma: Mouse models and the potential roles of proteases
- PMID: 27045475
- DOI: 10.1016/j.canlet.2016.03.047
Hepatocellular carcinoma: Mouse models and the potential roles of proteases
Abstract
Primary liver cancer is the second most common cause of mortality from cancer. The most common models of hepatocellular carcinoma, which use a chemical and/or metabolic insult, xenograft, or genetic manipulation, are discussed in this review. In the tumour microenvironment lymphocytes, fibroblasts, endothelial cells and antigen presenting cells are important determinants of cell fate. These cells make a range of proteases that modify the biological activity of other proteins, particularly extracellular matrix proteins that alter cell migration of tumour cells, fibroblasts and leucocytes, and chemokines that alter leucocyte migration. The DPP4 family of post-proline peptidase enzymes modifies cell movement and the activities of many bioactive molecules including growth factors and chemokines.
Keywords: Dipeptidyl peptidase; Fibroblast activation protein; Hepatocellular carcinoma; Mouse models.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.Mol Pharm. 2011 Oct 3;8(5):1538-48. doi: 10.1021/mp200137c. Epub 2011 Aug 19. Mol Pharm. 2011. PMID: 21770423
-
[Control of hepatocellular carcinoma progression by the tumor microenvironment].Bull Acad Natl Med. 2012 Jan;196(1):75-84. Bull Acad Natl Med. 2012. PMID: 23259335 French.
-
Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.Cancer Res. 2005 Oct 1;65(19):8861-8. doi: 10.1158/0008-5472.CAN-05-1318. Cancer Res. 2005. PMID: 16204057
-
Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.Liver Int. 2014 Jul;34(6):834-43. doi: 10.1111/liv.12465. Epub 2014 Feb 12. Liver Int. 2014. PMID: 24397349 Review.
-
Role of the microenvironment in hepatocellular carcinoma development and progression.Cancer Treat Rev. 2012 May;38(3):218-25. doi: 10.1016/j.ctrv.2011.06.010. Epub 2011 Jul 16. Cancer Treat Rev. 2012. PMID: 21763074 Review.
Cited by
-
Multiple liver insults synergize to accelerate experimental hepatocellular carcinoma.Sci Rep. 2018 Jul 6;8(1):10283. doi: 10.1038/s41598-018-28486-8. Sci Rep. 2018. PMID: 29980757 Free PMC article.
-
Evaluation of Polymer Nanoformulations in Hepatoma Therapy by Established Rodent Models.Theranostics. 2019 Feb 20;9(5):1426-1452. doi: 10.7150/thno.31683. eCollection 2019. Theranostics. 2019. PMID: 30867842 Free PMC article. Review.
-
Traditional Chinese Medicine as a Tool for the Treatment of Hepatocellular Carcinoma by Targeting Pathophysiological Mechanism.Cancer Manag Res. 2025 Apr 8;17:779-792. doi: 10.2147/CMAR.S513729. eCollection 2025. Cancer Manag Res. 2025. PMID: 40225699 Free PMC article. Review.
-
A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma.Int J Mol Sci. 2020 Jul 30;21(15):5461. doi: 10.3390/ijms21155461. Int J Mol Sci. 2020. PMID: 32751728 Free PMC article.
-
Animal models of cholangiocarcinoma.Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):982-992. doi: 10.1016/j.bbadis.2018.03.026. Epub 2018 Apr 5. Biochim Biophys Acta Mol Basis Dis. 2019. PMID: 29627364 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous